[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100638473":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":33,"centralContacts":34,"locations":40,"responsibleParty":210,"collaborators":33,"id":212,"slug":213,"hasResults":214,"nctId":215,"briefTitle":216,"officialTitle":217,"acronym":218,"eligibilityCriteria":219,"healthyVolunteers":214,"sex":220,"minAge":221,"maxAge":33,"enrollmentInfo":222,"targetDuration":33,"studyType":225,"phases":226,"briefSummary":228,"conditions":229,"keywords":232,"overallStatus":43,"whyStopped":33,"lastUpdateSubmitDate":233,"lastUpdatePostDateStruct":234,"startDateStruct":237,"completionDateStruct":239,"leadSponsor":241,"locationsCount":242},{"fullName":5,"class":6},"AstraZeneca","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Arm A","EXPERIMENTAL","Doses of AZD2389 to be administered orally.",[13],"Drug: AZD2389",{"label":15,"type":16,"description":17,"interventionNames":18},"Arm B","PLACEBO_COMPARATOR","Doses of placebo to be administered orally.",[19],"Other: Placebo",[21,28],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DRUG","AZD2389","potent, selective, first-in-class, small molecule oral inhibitor of FAP and is being developed for the treatment of CLDs with advanced hepatic fibrosis including cirrhosis.",[9],[27],"Active IMP",{"type":29,"name":30,"description":31,"armGroupLabels":32,"otherNames":33},"OTHER","Placebo","Oral administration",[15],null,[35],{"name":36,"role":37,"phone":38,"phoneExt":33,"email":39},"AstraZeneca Clinical Study Information Center","CONTACT","1-877-240-9479","information.center@astrazeneca.com",[41,55,63,72,80,88,98,106,115,124,132,141,150,159,168,176,184,192,197,205],{"facility":42,"status":43,"city":44,"state":45,"zip":46,"country":47,"countryCode":48,"cosmosGeoPoint":49,"geoPoint":54,"contacts":33},"Research Site","RECRUITING","Chandler","Arizona","85224","United States","US",{"type":50,"coordinates":51},"Point",[52,53],-111.84125,33.30616,{"lat":53,"lon":52},{"facility":42,"status":43,"city":56,"state":45,"zip":57,"country":47,"countryCode":48,"cosmosGeoPoint":58,"geoPoint":62,"contacts":33},"Tucson","85712",{"type":50,"coordinates":59},[60,61],-110.92648,32.22174,{"lat":61,"lon":60},{"facility":42,"status":43,"city":64,"state":65,"zip":66,"country":47,"countryCode":48,"cosmosGeoPoint":67,"geoPoint":71,"contacts":33},"Jupiter","Florida","33458",{"type":50,"coordinates":68},[69,70],-80.09421,26.93422,{"lat":70,"lon":69},{"facility":42,"status":43,"city":73,"state":65,"zip":74,"country":47,"countryCode":48,"cosmosGeoPoint":75,"geoPoint":79,"contacts":33},"Miami","33122",{"type":50,"coordinates":76},[77,78],-80.19366,25.77427,{"lat":78,"lon":77},{"facility":42,"status":43,"city":81,"state":65,"zip":82,"country":47,"countryCode":48,"cosmosGeoPoint":83,"geoPoint":87,"contacts":33},"Port Orange","32127",{"type":50,"coordinates":84},[85,86],-80.99561,29.13832,{"lat":86,"lon":85},{"facility":42,"status":89,"city":90,"state":91,"zip":92,"country":47,"countryCode":48,"cosmosGeoPoint":93,"geoPoint":97,"contacts":33},"NOT_YET_RECRUITING","Kansas City","Missouri","64131",{"type":50,"coordinates":94},[95,96],-94.57857,39.09973,{"lat":96,"lon":95},{"facility":42,"status":89,"city":99,"state":91,"zip":100,"country":47,"countryCode":48,"cosmosGeoPoint":101,"geoPoint":105,"contacts":33},"St Louis","63123",{"type":50,"coordinates":102},[103,104],-90.19789,38.62727,{"lat":104,"lon":103},{"facility":42,"status":43,"city":107,"state":108,"zip":109,"country":47,"countryCode":48,"cosmosGeoPoint":110,"geoPoint":114,"contacts":33},"Las Vegas","Nevada","89106",{"type":50,"coordinates":111},[112,113],-115.13722,36.17497,{"lat":113,"lon":112},{"facility":42,"status":43,"city":116,"state":117,"zip":118,"country":47,"countryCode":48,"cosmosGeoPoint":119,"geoPoint":123,"contacts":33},"Morehead City","North Carolina","28557",{"type":50,"coordinates":120},[121,122],-76.72604,34.72294,{"lat":122,"lon":121},{"facility":42,"status":43,"city":125,"state":117,"zip":126,"country":47,"countryCode":48,"cosmosGeoPoint":127,"geoPoint":131,"contacts":33},"Raleigh","27607",{"type":50,"coordinates":128},[129,130],-78.63861,35.7721,{"lat":130,"lon":129},{"facility":42,"status":43,"city":133,"state":134,"zip":135,"country":47,"countryCode":48,"cosmosGeoPoint":136,"geoPoint":140,"contacts":33},"Westlake","Ohio","44145",{"type":50,"coordinates":137},[138,139],-81.91792,41.45532,{"lat":139,"lon":138},{"facility":42,"status":43,"city":142,"state":143,"zip":144,"country":47,"countryCode":48,"cosmosGeoPoint":145,"geoPoint":149,"contacts":33},"Yukon","Oklahoma","73099",{"type":50,"coordinates":146},[147,148],-97.76254,35.50672,{"lat":148,"lon":147},{"facility":42,"status":89,"city":151,"state":152,"zip":153,"country":47,"countryCode":48,"cosmosGeoPoint":154,"geoPoint":158,"contacts":33},"Clarksville","Tennessee","37040",{"type":50,"coordinates":155},[156,157],-87.35945,36.52977,{"lat":157,"lon":156},{"facility":42,"status":43,"city":160,"state":161,"zip":162,"country":47,"countryCode":48,"cosmosGeoPoint":163,"geoPoint":167,"contacts":33},"Austin","Texas","78757",{"type":50,"coordinates":164},[165,166],-97.74306,30.26715,{"lat":166,"lon":165},{"facility":42,"status":89,"city":169,"state":161,"zip":170,"country":47,"countryCode":48,"cosmosGeoPoint":171,"geoPoint":175,"contacts":33},"Denison","75020",{"type":50,"coordinates":172},[173,174],-96.53666,33.75566,{"lat":174,"lon":173},{"facility":42,"status":43,"city":177,"state":161,"zip":178,"country":47,"countryCode":48,"cosmosGeoPoint":179,"geoPoint":183,"contacts":33},"Georgetown","78626",{"type":50,"coordinates":180},[181,182],-97.67723,30.63269,{"lat":182,"lon":181},{"facility":42,"status":43,"city":185,"state":161,"zip":186,"country":47,"countryCode":48,"cosmosGeoPoint":187,"geoPoint":191,"contacts":33},"Houston","77004",{"type":50,"coordinates":188},[189,190],-95.36327,29.76328,{"lat":190,"lon":189},{"facility":42,"status":43,"city":185,"state":161,"zip":193,"country":47,"countryCode":48,"cosmosGeoPoint":194,"geoPoint":196,"contacts":33},"77079",{"type":50,"coordinates":195},[189,190],{"lat":190,"lon":189},{"facility":42,"status":43,"city":198,"state":161,"zip":199,"country":47,"countryCode":48,"cosmosGeoPoint":200,"geoPoint":204,"contacts":33},"San Antonio","78215",{"type":50,"coordinates":201},[202,203],-98.49363,29.42412,{"lat":203,"lon":202},{"facility":42,"status":43,"city":198,"state":161,"zip":206,"country":47,"countryCode":48,"cosmosGeoPoint":207,"geoPoint":209,"contacts":33},"78222",{"type":50,"coordinates":208},[202,203],{"lat":203,"lon":202},{"type":211,"investigatorFullName":33,"investigatorTitle":33,"investigatorAffiliation":33,"oldNameTitle":33,"oldOrganization":33},"SPONSOR","100638473","phase-2-study-of-azd2389-safety-tolerability-and-pharmacodynamics-in-adults-with-steatotic-liver-disease-and-advanced-fibrosis-100638473",false,"NCT07610837","Study of AZD2389 Safety, Tolerability, and Pharmacodynamics in Adults With Steatotic Liver Disease and Advanced Fibrosis","A Phase IIa, Randomised, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of AZD2389 in Adult Participants With Steatotic Liver Disease and Advanced Fibrosis (BRAVO)","BRAVO","Key Inclusion Criteria:\n\n* Males\u002Ffemales aged 18 or over\n* A diagnosis of SLD with advanced fibrosis\n* No significant change in weight over the last 6 months\n* Contraceptive us by participants or participants partners\n* Capable of giving informed consent\n* Judged by the investigator to be suitable for study\n\nKey Exclusion Criteria:\n\n* Portal hypertension (LSM \\>25 kPa or 20-25 kPa with platelets \\\u003C150×10⁹\u002FL), decompensated liver disease, Child-Pugh \\>A6, MELD \\>12, other chronic liver diseases, prior\u002Fplanned liver transplant, or malignant liver tumors.\n* Positive viral infections, including HIV or hepatitis B, or hepatitis C unless HCV RNA-negative ≥12 weeks after treatment.\n* Alcohol intake above protocol thresholds, or positive screen for drugs of abuse.\n* Significant metabolic, cardiovascular, or GI disorders, including T1DM or insulin-treated T2DM, uncontrolled hypertension, recent major cardiac\u002Fcerebrovascular events, severe heart failure, serious arrhythmias, significant pancreatic disease, or major GI surgery.\n* History of psychosis, bipolar disorder, recent major depression, or suicide attempt\u002Fideation within 1 year.\n* Bleeding risk or wound-healing concerns, including coagulation disorders, major bleeding history, active wounds or recent major surgery, or severe dermatologic immune conditions.\n* Prohibited medications or hypersensitivities, including moderate\u002Fstrong CYP3A4 or BCRP\u002FOAT3 inhibitors\u002Finducers, anticoagulants\u002Fantiplatelets (except aspirin ≤81 mg\u002Fday), or hypersensitivity to DPP4 inhibitors.\n* Other protocol-defined exclusions, including significant abnormal labs (e.g., worsening ALT\u002FAST), recent participation in another IMP study, or investigator judgment of unsuitability.","ALL","18 Years",{"count":223,"type":224},104,"ESTIMATED","INTERVENTIONAL",[227],"PHASE2","The purpose of this study is to evaluate the safety, tolerability, and pharmacodynamic effects of AZD2389 in adult participants with steatotic liver disease (SLD) and advanced fibrosis.",[230,231],"Liver Fibrosis","Hepatic Cirrhosis",[230,231],"2026-06-25",{"date":235,"type":236},"2026-06-26","ACTUAL",{"date":238,"type":236},"2026-05-07",{"date":240,"type":224},"2027-07-07",{"name":5,"class":6},20]